Impaired fasting glucose, single-nucleotide polymorphisms, and risk for colorectal cancer in Koreans
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
OBJECTIVES: Numerous studies have demonstrated that fasting serum glucose (FSG) levels and certain single-nucleotide polymorphisms (SNPs) are related to an increased risk of colorectal cancer (CRC); however, their combined effects are still unclear. METHODS: Of a total of 144,527 men and women free of cancer at baseline, 317 developed CRC during 5.3 years of follow-up. A case-cohort study (n=1,691) was used, consisting of participants with a DNA sample available. Three well-known SNPs (rs3802842, rs6983267, rs10795668) were genotyped. Hazard ratios (HR) and 95% confidence intervals (CI) of CRC, colon and rectal cancer were calculated, with the Cox proportional hazard models. RESULTS: The crude incidence rates per 100,000 person-years were 41.1 overall, 48.4 for men, and 29.3 for women. Among participants with dysglycemia, SNPs rs3802842 and rs6983267 were both associated with an increased risk of CRC (HR, 3.2; 95% CI, 1.9 to 5.5 and HR, 1.8; 95% CI, 1.1 to 3.1, respectively) and rectal cancer (HR, 3.4; 95% CI, 1.8 to 6.6 and HR, 3.3; 95% CI, 1.6 to 7.1, respectively). The interaction effect of dysglycemia and SNPs was positive, that is, resulted in an elevated risk of CRC, but was not statistically significant. CONCLUSIONS: This study demonstrates that both high FSG and certain SNPs are major risk factors for CRC and rectal cancer but that they did not interact synergistically. The difference in effect size of the SNPs according to CRC subtype (i.e., colon or rectal cancer) and presence of dysglycemia merits further research.
Abstract
OBJECTIVES: Numerous studies have demonstrated that fasting serum glucose (FSG) levels and certain single-nucleotide polymorphisms (SNPs) are related to an increased risk of colorectal cancer (CRC); however, their combined effects are still unclear. METHODS: Of a total of 144,527 men and women free of cancer at baseline, 317 developed CRC during 5.3 years of follow-up. A case-cohort study (n=1,691) was used, consisting of participants with a DNA sample available. Three well-known SNPs (rs3802842, rs6983267, rs10795668) were genotyped. Hazard ratios (HR) and 95% confidence intervals (CI) of CRC, colon and rectal cancer were calculated, with the Cox proportional hazard models. RESULTS: The crude incidence rates per 100,000 person-years were 41.1 overall, 48.4 for men, and 29.3 for women. Among participants with dysglycemia, SNPs rs3802842 and rs6983267 were both associated with an increased risk of CRC (HR, 3.2; 95% CI, 1.9 to 5.5 and HR, 1.8; 95% CI, 1.1 to 3.1, respectively) and rectal cancer (HR, 3.4; 95% CI, 1.8 to 6.6 and HR, 3.3; 95% CI, 1.6 to 7.1, respectively). The interaction effect of dysglycemia and SNPs was positive, that is, resulted in an elevated risk of CRC, but was not statistically significant. CONCLUSIONS: This study demonstrates that both high FSG and certain SNPs are major risk factors for CRC and rectal cancer but that they did not interact synergistically. The difference in effect size of the SNPs according to CRC subtype (i.e., colon or rectal cancer) and presence of dysglycemia merits further research.
참고문헌 (19)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012", Cancer Research and Treatment, 47(2), pp.127~141 (2015), 대한암학회[DOI]
- Shin HY, "Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men : the Korean Cancer Prevention Study-II", Metabolism, 63, pp.1250~1256 (2014)
- Cheng TH, "Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP", Eur J Hum Genet, 23, pp.260~263 (2015)
- Rex DK, "Serrated lesions of the colorectum : review and recommendations from an expert panel", Am J Gastroenterol, 107, pp.1315~1329 (2012)
- Ling BS, "Attitudes toward colorectal cancer screening tests", J Gen Intern Med, 16, pp.822~830 (2001)
- Duffy MJ, "Tumour markers in colorectal cancer : European Group on Tumour Markers(EGTM)guidelines for clinical use", Eur J Cancer, 43, pp.1348~1360 (2007)
- Yarnall JM, "Incorporating non-genetic risk factors and behavioural modifications into risk prediction models for colorectal cancer", Cancer Epidemiol, 37, pp.324~329 (2013)
- Fletcher RH, "Carcinoembryonic antigen", Ann Intern Med, 104, pp.66~73 (1986)
- Freedman AN, "Colorectal cancer risk prediction tool for white men and women without known susceptibility", J Clin Oncol, 27, pp.686~693 (2009)
- Ish-Shalom D, "Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor", Diabetologia, 40(Suppl 2), pp.S25~S31 (1997)
- Khandwala HM, "The effects of insulin-like growth factors on tumorigenesis and neoplastic growth", Endocr Rev, 21, pp.215~244 (2000)
- Yu H, "STATs in cancer inflammation and immunity : a leading role for STAT3", Nat Rev Cancer, 9, pp.798~809 (2009)
- Straus DS, "TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells", Mol Cancer, 12, pp.78~ (2013)
- Will JC, "Colorectal cancer: another complication of diabetes mellitus?", Am J Epidemiol, 147, pp.816~825 (1998)
- Stadler J, "Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer", Cancer Lett, 38, pp.315~320 (1988)
- Tlaskalová-Hogenová H, "The role of gut microbiota(commensal bacteria)and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer : contribution of germ-free and gnotobiotic animal models of human diseases", Cell Mol Immunol, 8, pp.110~120 (2011)
- Houlston RS, "Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33", Nat Genet, 42, pp.973~977 (2010)
- Carvajal-Carmona LG, "Much of the genetic risk of colorectal cancer is likely to be mediated through susceptibility to adenomas", Gastroenterology, 144, pp.53~55 (2013)
- Dunlop MG, "Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals", Gut, 62, pp.871~881 (2013)